Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from AstraZeneca Pharma India Limited ( (IN:ASTRAZEN) ).
AstraZeneca Pharma India Limited has submitted a certificate to the stock exchanges, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This compliance ensures the company’s adherence to regulatory standards, potentially reinforcing its credibility and operational integrity in the market.
More about AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited operates in the pharmaceutical industry, focusing on the development and commercialization of prescription medicines. The company is known for its innovative products in various therapeutic areas, including oncology, cardiovascular, renal, and metabolic diseases.
Average Trading Volume: 670
Technical Sentiment Signal: Strong Buy
Current Market Cap: 230.3B INR
See more insights into ASTRAZEN stock on TipRanks’ Stock Analysis page.